Pettinga Financial Advisors LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,340 shares of the exchange traded fund’s stock after selling 870 shares during the period. Pettinga […]